Advanced Urothelial Carcinoma VL

Updates on Health-Related Quality-of-Life (HRQoL) analyses in GU Oncology - Cora Sternberg

Details
(Length of Discussion: 10 min) Cora Sternberg highlights from a number of key treatments in GU Oncology in a discussion wiht Alicia Morgans. Results from the only Phase 3 health-related quality-of-life (HRQoL) analyses in urothelial carcinoma from the KEYNOTE-045 study delivers results for patients who received 2 nd line therapy. A relevant discussion follows on a Phase 2 trial investigating 3 dif...

Immune Checkpoint Inhibitors and the Effects on Anti-Tumor Response - Daniel Petrylak

Details
Dr. Daniel Petrylak describes what an immune checkpoint inhibitor is and how this may effect an anti-tumor response. The immune system has several key attributes- it is specific, it has a memory and it can adapt to changes that are going on with tumor cells. He goes on to describe the mechanisms involved in the cancer cells response. (presentation in 2:40). BIOGRAPHY As Professor of Medicine and U...
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe